Impact of COVID-19 Pandemic on Treatment and Outcome of Patients With Femoropopliteal Peripheral Arterial Disease
J Soc Cardiovasc Angiogr Interv
.
2025 Jul 31;4(9):103816.
doi: 10.1016/j.jscai.2025.103816.
eCollection 2025 Sep.
Authors
Mohammadreza Naderian
1
,
Jun Li
2
,
Yulanka Castro-Dominguez
2
,
Tarek Hammad
2
,
Clint Oommen
2
,
Herbert D Aronow
3
,
Eric A Secemsky
4
,
Mehdi H Shishehbor
2
Affiliations
1
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
2
University Hospitals Harrington Heart and Vascular Institute, Case Western Reserve University, Cleveland, Ohio.
3
Division of Cardiovascular Medicine, Henry Ford Health Heart & Vascular, Detroit, Michigan.
4
Smith Center for Outcomes Research, Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
PMID:
41040434
PMCID:
PMC12485549
DOI:
10.1016/j.jscai.2025.103816
No abstract available
Keywords:
femoropopliteal; pandemic; peripheral arterial disease.